Azelis Group NV (AZE) fair value: what the stock is really worth
As of Sep 25, 2026: fair value of Azelis Group NV €10.61, price €12.10, upside -12.3%, quality 54 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch Azelis Group NV for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.
How to read this chart
60‑month range €6.79 – €26.52 · fair‑value band €8.29 – €13.80 · the €12.10 price screens above the €10.61 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 24, 2026.
Follow Azelis Group in your weekly email
Every Wednesday you see whether Azelis Group is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Azelis Group NV engages in the distribution of specialty chemicals and food ingredients.
Show more
Azelis Group NV engages in the distribution of specialty chemicals and food ingredients. The company provides specialty chemical products used in the life sciences, such as personal care, home care, industrial cleaning, pharmaceuticals, healthcare, food and nutrition, animal nutrition, agricultural environmental, flavours and fragrances, and nutraceuticals solutions; and industrial chemicals industry, including CASE, advanced materials and additives, lubricants, metalworking fluids, electronics, essential and fine chemicals, textiles, leather, and paper markets. It operates in Europe, Middle East, and Africa, as well as the Americas and the Asia-Pacific. Azelis Group NV was founded in 1996 and is headquartered in Antwerp, Belgium.
Stock analysis
Azelis Group NV (AZE) currently trades at €12.10, while our model-based Fair Value estimate is €10.61, implying the stock looks roughly 14.0% overvalued today.
Show more
Valuation
Bull case: the DCF Models group reads highest at a median of €22.20 per share, and 10 of the 26 models we run sit above the €12.10 price.
Bear case: the Dividend Discount group reads lowest at €3.41, and 16 of the 26 models stay below the price. Evidence for this calculation is high.
Scenario range: €8.29 (bear) to €13.80 (bull), the price of €12.10 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 54/100 (solid quality), in the Basic Materials sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Azelis Group NV reported revenue of €4.1B in FY2025 versus €2.8B in FY2021, a compound +9.8%/yr. Reported net income was €111M in FY2025, compounding +13.2%/yr from FY2021.
Key figures
Market cap €2.9B · P/E ratio 25.7 · P/S ratio 0.70 · EPS (TTM) €0.4700 · Dividend yield 1.9% · Net margin 2.7% · Return on equity 4.1% · Return on assets (EBIT) 6.3%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 50 out of 100 (low confidence).
What moves the price
The share trades about 4% below its 52-week high and 78% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Basic Materials peers we cover trades at −54% fair-value upside, at −12%, AZE screens cheaper than that median.
Fair Value models
Bear €8.29Fair Value €10.61Bull €13.80
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 9 months old). Earnings retained since then (€0.1798 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.74/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
−3.0%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−0.1%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+11.9%
Start year 2020 (pandemic)
Revenue growth 7 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+48.6%
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Basis: EBIT basis.
+12.1%
Earnings growth per share plus dividend.
Earnings per share, growth per year+10.2%
Dividend (yield on the price)1.9%
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.7% → 7%
Growth Forecast
Price in line with expectations
The price assumes less growth than the company has delivered so far and about what analysts expect.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+3.1%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+3.2%
Yearly sales growth analysts expect, extended to five years.
After inflation (euro area: IMF forecast 2.2% a year to 2030, 2.6% from 2016 to 2025) that is about +0.9% a year for the price and +1.0% for the forecasts.
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Specialty Chemicals · 708 stocks
Beats the industry median on 6/13 measures
A mixed picture versus its industry peers.
Valuation
Quality Score54 · Above median
Fair Value upside−12% · Above median
Profitability
Return on equity (TTM)4% · Below median
Return on assets4% · Above median
Net margin (TTM)3% · Below median
Operating margin (TTM)9% · Above median
Growth and dividend
Revenue growth0% · Below median
Dividend yield (TTM)1.9% · Above median
Balance sheet
Debt / equity0.60× · Highest 25%
Valuation Multiplesvs Specialty Chemicals median · lower = cheaper
P/E (TTM)25.7× · Pricier than median
P/B1.24× · book value is mostly goodwill ⓘGoodwill and other intangible assets are larger than the equity. The book value mainly reflects prices paid for past acquisitions, so we do not rank this P/B against the peer group.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Azelis Group NV Fair Value". https://www.fairvalue-calculator.com/stock/AZE
Frequently asked questions
Is Azelis Group NV (AZE) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of €10.61 versus a price of €12.10, about −12% upside (overvalued).
What is the fair value of AZE?
Our model-based fair value for Azelis Group NV is €10.61 (as of Sep 24, 2026), built from audited fundamentals. The current price: €12.10.
What is the quality score of AZE?
Azelis Group NV has a Quality Score of 54/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Azelis Group NV (AZE)?
Our model-based price target is the fair value of €10.61 (as of Sep 24, 2026) from 26 valuation models. Cautious scenario €8.29, optimistic scenario €13.80. It is a calculation from audited fundamentals, not an analyst target.
What is the Azelis Group NV stock forecast for 2026?
Our models put fair value at €10.61, about −12% upside versus a price of €12.10 (overvalued). Cautious scenario €8.29, optimistic scenario €13.80. The calculation is refreshed regularly with new filings.
What is the revenue of Azelis Group NV (AZE)?
Azelis Group NV reported trailing-twelve-month revenue of about €4.1B (latest available figure, as of Sep 24, 2026).
Does Azelis Group NV pay a dividend?
Azelis Group NV currently shows a dividend yield of about 1.87% relative to its recent price (as of Sep 24, 2026).
What growth is priced into Azelis Group NV (AZE)?
For today's price to be fair in a discounted-cash-flow model, Azelis Group NV would have to grow free cash flow by +3.1 % per year for five years (discount rate 9.1 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +11.9 % per year. As of Sep 24, 2026.
What discount rate (WACC) does the fair value of AZE use?
Our models discount Azelis Group NV at 9.1 %: a base by market capitalisation (mid), damped by beta 0.54, country premium for Belgium. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Azelis Group NV that is +3.1 % per year a year over ten years, using the same discount rate (9.1 %) and the same formula as our fair value.
How much growth has Azelis Group NV (AZE) delivered so far?
Over the past 5 years revenue at Azelis Group NV grew +11.9 % a year. The price currently implies +3.1 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Azelis Group NV (AZE) growing?
The median revenue growth in the sector is +3.5 % a year. That is the yardstick for the growth priced into Azelis Group NV (+3.1 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Azelis Group NV (AZE)?
The free-cash-flow yield on the price is 9.78 %: that much free cash flow Azelis Group NV produces per unit of market value. When it exceeds the discount rate of our models (9.1 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Azelis Group NV (AZE)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Azelis Group NV it is €10.61 per share (as of Sep 24, 2026), against a price of €12.10. It is the blended result of 26 valuation models (cash flow, earnings, asset, dividend).
Is Azelis Group NV stock overvalued or undervalued in 2026?
As of Sep 24, 2026, AZE trades above its calculated fair value: price €12.10, fair value €10.61, a gap of about −12% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of AZE?
No. The price is what the market pays today (€12.10); the fair value is what the company's own numbers justify (€10.61). For Azelis Group NV the two are €1.49 per share apart. That gap is exactly why we show both numbers side by side.
How much is Azelis Group NV worth?
The market values Azelis Group NV at about €2.9B (market capitalisation, as of Sep 24, 2026). Per share that is €12.10; our models calculate a fair value of €10.61 per share.
What do the bullish and bearish scenarios say about AZE?
Our models span a range for Azelis Group NV: cautious scenario €8.29, base €10.61, optimistic €13.80 per share (as of Sep 24, 2026, price €12.10). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of AZE?
Azelis Group NV trades at a price-to-earnings ratio of 25.7 (as of Sep 24, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of €10.61 is built from several models across several years. Other multiples: P/B 1.2, P/S 0.8, EV/EBITDA 11.5.
How solid is the balance sheet of Azelis Group NV (AZE)?
Balance-sheet figures for Azelis Group NV (as of Sep 24, 2026): return on equity 4.1%, debt of 0.60 per unit of equity. They feed the Quality Score of 54/100, which measures business quality independently of the share price.
How far is AZE from its 52-week high?
Azelis Group NV trades at €12.10, about 4% below its 52-week high of €12.57 and 78% above the low of €6.79 (as of Sep 25, 2026). Distance from the high says nothing about value: that is what the fair value of €10.61 is for.
Which stocks are comparable to Azelis Group NV?
From the same area (Basic Materials) we also value Linde plc, The Sherwin-Williams Company, Ecolab Inc, Air Products and Chemicals, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Azelis Group NV stock attractive at the current price?
The data as of Sep 24, 2026: price €12.10, calculated fair value €10.61 (−12%), Quality Score 54/100, from 26 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of AZE calculated?
We run Azelis Group NV through 26 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of €10.61, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.2 % above its aggregate fair value. Azelis Group NV itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Azelis Group NV (AZE)?
The closing price on Sep 25, 2026 was €12.10. Our model-based fair value is €10.61, about −12% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Azelis Group NV right now?
Solid but not exceptional quality (54/100) and above fair value, neither a clear bargain nor a standout compounder. The price sits in the upper half of our model range, so the margin of safety is thin. The data supports the verdict: every model runs on fully documented inputs.
Key figures of Azelis Group NV
How large is the market capitalisation of Azelis Group NV (AZE)?
The market capitalisation of Azelis Group NV is €2.9B. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Azelis Group NV (AZE)?
The price-to-sales ratio of Azelis Group NV is 0.70 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Azelis Group NV (AZE)?
Earnings per share at Azelis Group NV are €0.4700 (price ÷ EPS = P/E 25.7). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Azelis Group NV (AZE)?
The dividend yield of Azelis Group NV is 1.9% (payout 48.1%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Azelis Group NV (AZE)?
The net margin of Azelis Group NV is 2.7% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Azelis Group NV (AZE)?
The return on equity (ROE) of Azelis Group NV is 4.1% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Azelis Group NV (AZE)?
On an EBIT basis the return on assets of Azelis Group NV is 6.3% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Azelis Group NV (AZE)?
The operating margin of Azelis Group NV is 8.7% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Azelis Group NV (AZE)?
Revenue at Azelis Group NV is growing +0.3% versus a year earlier (3y avg −0.1%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Azelis Group NV (AZE)?
Earnings per share at Azelis Group NV are growing +2.9% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Azelis Group NV (AZE) carry?
The net debt of Azelis Group NV is €1.7B (fiscal year 2025, ≈ 6.1 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Azelis Group NV in the live analysis
One click puts Azelis Group NV on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
Broad data
Sep 24, 2026